Mark A. Prygocki Sr.

Chief Financial Officer, MEDICIS PHARMACEUTICAL CORP.

Companies

Verrica Pharmaceuticals Inc.Board member Jun 14, 2018 to now¹
Clarus Therapeutics (United States)Board member Sep 13, 2021 to Jun 9, 2022²
Revance Therapeutics, Inc.Board member May 14, 2014 to May 9, 2016³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Clarus Therapeutics (United States)5,766 shares⁴Jun 7, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 7, 2022Granted 1,922 shares of Clarus Therapeutics (United States)⁴
Dec 12, 2021Granted 3,844 shares of Clarus Therapeutics (United States)⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVerrica Pharmaceuticals Inc., Board member
2
SEC EDGARClarus Therapeutics (United States), Board member
3
SEC EDGARRevance Therapeutics, Inc., Board member
4
SEC EDGARClarus Therapeutics (United States) shares after the filing of Jun 7, 2022
5
SEC EDGARForm 4 filed Dec 14, 2021